These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28479180)
21. Antimalarial antibody repertoire defined by plasma IG proteomics and single B cell IG sequencing. Coelho CH; Nadakal ST; Gonzales Hurtado P; Morrison R; Galson JD; Neal J; Wu Y; King CR; Price V; Miura K; Wong-Madden S; Alamou Doritchamou JY; Narum DL; MacDonald NJ; Snow-Smith M; Vignali M; Taylor JJ; Lefranc MP; Trück J; Long CA; Healy SA; Sagara I; Fried M; Duffy PE JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33048842 [TBL] [Abstract][Full Text] [Related]
22. Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. Tiwari S; Goyal AK; Mishra N; Khatri K; Vaidya B; Mehta A; Wu Y; Vyas SP J Control Release; 2009 Dec; 140(2):157-65. PubMed ID: 19686788 [TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. Sirima SB; Durier C; Kara L; Houard S; Gansane A; Loulergue P; Bahuaud M; Benhamouda N; Nebié I; Faber B; Remarque E; Launay O; Vaccine; 2017 Oct; 35(45):6218-6227. PubMed ID: 28947345 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Parzych EM; Miura K; Ramanathan A; Long CA; Burns JM Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28993460 [TBL] [Abstract][Full Text] [Related]
25. A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate. Noe AR; Espinosa D; Li X; Coelho-Dos-Reis JG; Funakoshi R; Giardina S; Jin H; Retallack DM; Haverstock R; Allen JR; Vedvick TS; Fox CB; Reed SG; Ayala R; Roberts B; Winram SB; Sacci J; Tsuji M; Zavala F; Gutierrez GM PLoS One; 2014; 9(9):e107764. PubMed ID: 25247295 [TBL] [Abstract][Full Text] [Related]
27. Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons. Kumar R; Nyakundi R; Kariuki T; Ozwara H; Nyamongo O; Mlambo G; Ellefsen B; Hannaman D; Kumar N Vaccine; 2013 Jun; 31(31):3140-7. PubMed ID: 23684840 [TBL] [Abstract][Full Text] [Related]
28. A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses. Jones RM; Chichester JA; Manceva S; Gibbs SK; Musiychuk K; Shamloul M; Norikane J; Streatfield SJ; van de Vegte-Bolmer M; Roeffen W; Sauerwein RW; Yusibov V Hum Vaccin Immunother; 2015; 11(1):124-32. PubMed ID: 25483525 [TBL] [Abstract][Full Text] [Related]
29. Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles. Kumar R; Ledet G; Graves R; Datta D; Robinson S; Bansal GP; Mandal T; Kumar N Pharm Res; 2015 Dec; 32(12):3827-36. PubMed ID: 26113235 [TBL] [Abstract][Full Text] [Related]
30. Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. Kubler-Kielb J; Majadly F; Wu Y; Narum DL; Guo C; Miller LH; Shiloach J; Robbins JB; Schneerson R Proc Natl Acad Sci U S A; 2007 Jan; 104(1):293-8. PubMed ID: 17190797 [TBL] [Abstract][Full Text] [Related]
31. Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates. Lee SM; Wu CK; Plieskatt J; McAdams DH; Miura K; Ockenhouse C; King CR Malar J; 2016 Aug; 15(1):405. PubMed ID: 27515826 [TBL] [Abstract][Full Text] [Related]
32. A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice. Jones RM; Chichester JA; Mett V; Jaje J; Tottey S; Manceva S; Casta LJ; Gibbs SK; Musiychuk K; Shamloul M; Norikane J; Mett V; Streatfield SJ; van de Vegte-Bolmer M; Roeffen W; Sauerwein RW; Yusibov V PLoS One; 2013; 8(11):e79538. PubMed ID: 24260245 [TBL] [Abstract][Full Text] [Related]
33. Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. Kumar R; Ray PC; Datta D; Bansal GP; Angov E; Kumar N Vaccine; 2015 Sep; 33(39):5064-71. PubMed ID: 26299750 [TBL] [Abstract][Full Text] [Related]